Wells Fargo’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-217
| Closed | -$143 | – | 7162 |
|
|
2024
Q2 | $143 | Sell |
217
-156
| -42% | -$97 | ﹤0.01% | 6219 |
|
|
2024
Q1 | $225 | Buy |
373
+157
| +73% | +$96 | ﹤0.01% | 6467 |
|
|
2023
Q4 | $127 | Buy |
216
+7
| +3% | +$4 | ﹤0.01% | 6713 |
|
|
2023
Q3 | $140 | Sell |
209
-331
| -61% | -$406 | ﹤0.01% | 6675 |
|
|
2023
Q2 | $1.78K | Sell |
540
-669
| -55% | -$2.02K | ﹤0.01% | 6231 |
|
|
2023
Q1 | $11K | Buy |
1,209
+1,142
| +1,704% | +$16.2K | ﹤0.01% | 5836 |
|
|
2022
Q4 | $783 | Sell |
67
-133
| -67% | -$2.35K | ﹤0.01% | 6263 |
|
|
2022
Q3 | $4K | Sell |
200
-76
| -28% | -$2.05K | ﹤0.01% | 6003 |
|
|
2022
Q2 | $7K | Sell |
276
-1,449
| -84% | -$49.3K | ﹤0.01% | 5918 |
|
|
2022
Q1 | $85K | Sell |
1,725
-2,065
| -54% | -$102K | ﹤0.01% | 5406 |
|
|
2021
Q4 | $266K | Buy |
3,790
+3,604
| +1,938% | +$304K | ﹤0.01% | 5109 |
|
|
2021
Q3 | $17K | Sell |
186
-732
| -80% | -$69.5K | ﹤0.01% | 6030 |
|
|
2021
Q2 | $92K | Sell |
918
-3,456
| -79% | -$337K | ﹤0.01% | 5328 |
|
|
2021
Q1 | $409K | Sell |
4,374
-3,052
| -41% | -$309K | ﹤0.01% | 4796 |
|
|
2020
Q4 | $613K | Buy |
7,426
+2,036
| +38% | +$174K | ﹤0.01% | 4383 |
|
|
2020
Q3 | $462K | Sell |
5,390
-1,287
| -19% | -$150K | ﹤0.01% | 4405 |
|
|
2020
Q2 | $621K | Buy |
6,677
+3,117
| +88% | +$172K | ﹤0.01% | 4167 |
|
|
2020
Q1 | $102K | Buy |
3,560
+2,812
| +376% | +$109K | ﹤0.01% | 5045 |
|
|
2019
Q4 | $31K | Buy |
748
+437
| +141% | +$9.57K | ﹤0.01% | 5643 |
|
|
2019
Q3 | $4K | Buy |
311
+290
| +1,381% | +$6.07K | ﹤0.01% | 6122 |
|
|
2019
Q2 | $1K | Buy |
+21
| New | +$1.14K | ﹤0.01% | 6302 |
|
|
2018
Q2 | – | Sell |
-642
| Closed | -$67K | – | 6654 |
|
|
2018
Q1 | $67K | Buy |
642
+466
| +265% | +$55.6K | ﹤0.01% | 5466 |
|
|
2017
Q4 | $22K | Buy |
176
+126
| +252% | +$15.5K | ﹤0.01% | 5779 |
|
|
2017
Q3 | $6K | Buy |
+50
| New | +$6.01K | ﹤0.01% | 5993 |
|